Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ropivacaine fascia iliaca block with or without dexamethasone for hip fracture pain
ACTRN12621000789864Phase 2Recruiting
- Sponsor
- BioNet
- Start
- Oct 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in hip fracture comparing Ropivacaine + dexamethasone with Ropivacaine + placebo (2 arms). Primary endpoint: Duration of analgesia. Started Oct 2021; status: recruiting.
02
Drugs
ropivacainedexamethasone
03
Conditions
hip fracture
Beyond the preview
Go deeper on ACTRN12621000789864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000789864.